In addition to the new US headquarters facility, Patheon has opened a new pharmaceutical development laboratory in Research Triangle Park. This laboratory will support Patheon’s current US-based pharmaceutical development operations in Cincinnati and will initially offer stability studies, validation testing and analytical chemistry services.
Wes Wheeler, CEO and president of Patheon, said: “North Carolina is a rapidly growing center for the pharmaceutical industry, which now boasts 334 biotechnology-related companies. It is a pro-business community which combines attractive corporate incentives with a high quality of life for our employees. We are delighted to open our new US headquarters and our new laboratory here, in the vicinity of Research Triangle Park.”